| Globus Pallidus interna (GPi) Neurons | |
|---|---|
| Allen Atlas ID | CS202210140_3525 |
| Lineage | Neuron > GABAergic > Basal ganglia output |
| Markers | GAD1, GAD2, PPP1R1B, CALB1, FOXP2 |
| Brain Regions | Globus pallidus interna, Entopeduncular nucleus |
| Disease Vulnerability | [Parkinson's Disease](/diseases/parkinsons-disease), [Huntington's Disease](/diseases/huntingtons), Dystonia |
Globus Pallidus Interna (Gpi) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Globus Pallidus interna (GPi) Neurons are a specialized cell type classified within the Neuron > GABAergic > Basal ganglia output lineage. These cells are primarily found in Globus pallidus interna, Entopeduncular nucleus and are characterized by expression of marker genes including GAD1, GAD2, PPP1R1B, CALB1. They are selectively vulnerable in Parkinson's Disease, Huntington's Disease, Dystonia.
Globus Pallidus interna (GPi) Neurons are identified by the expression of the following key marker genes:
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification, as catalogued in the Allen Cell Type Atlas.
Globus Pallidus interna (GPi) Neurons play essential roles in neural circuits and brain function. They are found in the following brain regions:
Their normal functions include maintaining neural circuit integrity, signal processing, and contributing to the homeostasis of their local microenvironment.
Globus Pallidus interna (GPi) Neurons show selective vulnerability in the following neurodegenerative conditions:
The selective vulnerability of these cells is an active area of research, with factors including metabolic demands, calcium handling, exposure to toxic protein aggregates, and cell-autonomous gene expression programs contributing to their susceptibility.
Single-cell and single-nucleus RNA sequencing studies have revealed the transcriptomic signature of Globus Pallidus interna (GPi) Neurons. Key differentially expressed genes from the Allen Cell Type Atlas and related datasets include the marker genes listed above. These transcriptomic profiles help identify subtypes and disease-associated gene expression changes.
The study of Globus Pallidus Interna (Gpi) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The Globus Pallidus interna plays a critical role in the basal ganglia motor circuit and is profoundly affected in Parkinson's disease. In the PD state, excessive inhibitory output from the GPi contributes to the characteristic motor symptoms of bradykinesia, rigidity, and tremor[1].
The hyperdirect pathway provides rapid cortical input to the subthalamic nucleus (STN) via the pontine tegmentum, bypassing the striatum. This pathway is crucial for rapid movement suppression and is altered in PD[2].
The indirect pathway originates from striatal D2-medium spiny neurons that project to the external globus pallidus (GPe), which then projects to the subthalamic nucleus (STN). STN excitatory output drives GPi activity, increasing inhibitory projections to thalamocortical neurons[3].
In Huntington's disease, early loss of striatal medium spiny neurons leads to decreased GPi inhibition, resulting in hyperkinetic movements (chorea, dystonia). The GPi has emerged as a target for deep brain stimulation in HD[4].
High-frequency stimulation of the GPi is an established treatment for advanced Parkinson's disease and dystonia. GPi-DBS reduces motor complications and allows for reduced medication dosages[5].
Pallidotomy (surgical lesioning of the GPi) has been used to treat PD and dystonia, with beneficial effects on dyskinesias and motor symptoms[6].
GPi neurons express high levels of:
DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Neurologic Clinics. 2007. ↩︎
Aron AR, Herz N, Brown P, et al. Frontostriatal-subthalamic phase coherence underlying action inhibition. Journal of Neuroscience. 2016. ↩︎
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-striato-pallido-thalamo-cortical loop. Brain Research Reviews. 1995. ↩︎
Gonzalez-Alegre P, Roach L. Surgical approaches to Huntington's disease. Handbook of Clinical Neurology. 2021. ↩︎
Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease. Neurology. 2009. ↩︎
Fine J, Duff J, Chen R, et. al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. Brain. 2000. ↩︎